Skip to Content
Merck
CN

27506

L-(+)-Tartaric acid

puriss., meets analytical specification of Ph. Eur., NF, 99.7-100.5% (calc. to the dried substance), powder

Synonym(s):

(2R,3R)-(+)-Tartaric acid, L-Threaric acid

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
HO2CCH(OH)CH(OH)CO2H
CAS Number:
Molecular Weight:
150.09
UNSPSC Code:
12352106
NACRES:
NA.25
PubChem Substance ID:
EC Number:
201-766-0
Beilstein/REAXYS Number:
1725147
MDL number:
Assay:
99.7-100.5% (calc. to the dried substance)
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


vapor density

5.18 (vs air)

Quality Level

grade

puriss.

assay

99.7-100.5% (calc. to the dried substance)

form

powder

optical activity

[α]20/D +12.0 to +12.8°, c = 20% in H2O

autoignition temp.

797 °F

quality

meets analytical specification of Ph. Eur., NF

impurities

organic volatile impurities, complies (GC), residual solvents, complies, ≤0.001% heavy metals (as Pb)

ign. residue

≤0.05% (as SO4)

loss

≤0.2% loss on drying, 105 °C

mp

168-170 °C, 170-172 °C (lit.)

solubility

water: soluble 150 g/L at 20 °C

anion traces

chloride (Cl-): ≤100 mg/kg, oxalate (C2O42-): in accordance, oxalate (as oxalic acid): ≤100 mg/kg, sulfate (SO42-): ≤100 mg/kg

cation traces

As: ≤2 mg/kg, Ca: ≤200 mg/kg, Cu: ≤10 mg/kg, Hg: ≤1 mg/kg, Pb: ≤2 mg/kg, Zn: ≤10 mg/kg

suitability

complies for appearance of solution

application(s)

pharmaceutical (small molecule)

SMILES string

O[C@H]([C@@H](O)C(O)=O)C(O)=O

InChI

1S/C4H6O6/c5-1(3(7)8)2(6)4(9)10/h1-2,5-6H,(H,7,8)(H,9,10)/t1-,2-/m1/s1

InChI key

FEWJPZIEWOKRBE-JCYAYHJZSA-N



Still not finding the right product?

Explore all of our products under L-(+)-Tartaric acid


pictograms

Corrosion

signalword

Danger

hcodes

Hazard Classifications

Eye Dam. 1

Storage Class

11 - Combustible Solids

wgk

WGK 1

flash_point_f

302.0 °F - closed cup

flash_point_c

150 °C - closed cup

ppe

dust mask type N95 (US), Eyeshields, Gloves



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



M Alsina et al.
Blood, 87(4), 1495-1501 (1996-02-15)
Osteolytic bone destruction and its complications, bone pain, pathologic fractures, and hypercalcemia, are a major source of morbidity and mortality in patients with multiple myeloma. The bone destruction in multiple myeloma is due to increased osteoclast (OCL) activity and decreased
A A Cole et al.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 35(2), 203-206 (1987-02-01)
Tartrate-resistant acid phosphatase (TRAP) has been proposed as a cytochemical marker for osteoclasts. We have developed an improved technique for the localization of TRAP in rat and mouse bone and cartilage. This procedure employs JB-4 plastic as the embedding medium
Mark D Eddleston et al.
Chemical communications (Cambridge, England), 48(92), 11340-11342 (2012-10-18)
The formation of diastereomeric cocrystals of malic acid and tartaric acid was investigated by liquid-assisted grinding in the solid state. We demonstrate that racemic malic acid can be converted into two distinct diastereomeric cocrystal phases by grinding with a single



Global Trade Item Number

SKUGTIN
27506-1KG-R04061826723531
27506-25KG-R04061833606094